search
Back to results

Energy Specific Far Infrared Radiation Treatment for AIDS

Primary Purpose

HIV Infections

Status
Unknown status
Phase
Phase 1
Locations
Canada
Study Type
Interventional
Intervention
Far infrared
Sponsored by
GAAD Medical Research Institute Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for HIV Infections focused on measuring HIV, AIDS, Radiation, Far infrared, Treatment, Acquired Immunodeficiency Syndrome, Complimentary therapies

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 1 Year and above

Exclusion Criteria:

  • None

Sites / Locations

  • The Centre for Incurable Diseases

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

1

Arm Description

Infrared Radiation, wavelength between 5 and 20 microns

Outcomes

Primary Outcome Measures

The primary end point is to determine the therapeutic effects of far infrared radiation (5μm to 15μm wavelength) on HIV/AIDS.

Secondary Outcome Measures

Full Information

First Posted
December 12, 2007
Last Updated
August 14, 2009
Sponsor
GAAD Medical Research Institute Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT00574522
Brief Title
Energy Specific Far Infrared Radiation Treatment for AIDS
Official Title
Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for HIV/AIDS
Study Type
Interventional

2. Study Status

Record Verification Date
August 2009
Overall Recruitment Status
Unknown status
Study Start Date
February 2008 (undefined)
Primary Completion Date
August 2009 (Actual)
Study Completion Date
November 2009 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
GAAD Medical Research Institute Inc.

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators are proposing that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby enhancing the production of killer cells to fight and destroy the human immunodeficiency virus.
Detailed Description
Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS or Aids) is a collection of symptoms and infections resulting from the specific damage to the immune system caused by the human immunodeficiency virus (HIV) in humans. The late stage of the condition leaves individuals prone to opportunistic infections and tumors. Although treatments for AIDS and HIV exist to slow the virus' progression, there is no known cure. The investigators are postulating that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby enhancing the production of CD4+ T cells and other killer cells to fight and destroy the human immunodeficiency virus. The primary end point is to determine the therapeutic effects of far infrared radiation (5μm to 20μm wavelength) on HIV/AIDS.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections
Keywords
HIV, AIDS, Radiation, Far infrared, Treatment, Acquired Immunodeficiency Syndrome, Complimentary therapies

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
3 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Other
Arm Description
Infrared Radiation, wavelength between 5 and 20 microns
Intervention Type
Radiation
Intervention Name(s)
Far infrared
Intervention Description
Far infrared radiation with the wavelength between 5μm and 20μm for 30 to 40 minutes per session.
Primary Outcome Measure Information:
Title
The primary end point is to determine the therapeutic effects of far infrared radiation (5μm to 15μm wavelength) on HIV/AIDS.
Time Frame
One year

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 1 Year and above Exclusion Criteria: None
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ken Nedd, M.D.
Organizational Affiliation
GAAD Medical Research Institute Inc.
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Kwasi Donyina, Ph.D.
Organizational Affiliation
GAAD Medical Research Institute Inc.
Official's Role
Study Director
Facility Information:
Facility Name
The Centre for Incurable Diseases
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4V 1L5
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Energy Specific Far Infrared Radiation Treatment for AIDS

We'll reach out to this number within 24 hrs